Host response to post-operative pneumonia
Host response to post-operative pneumonia
批准号:
6511162
负责人:
PAUL R KNIGHT III
金额:
$39.0万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-07-01 至 2006-05-31
关键词:
Escherichia coli Orthomyxoviridae anesthesia bacterial pneumonia bactericidal immunity disease /disorder model influenza interferon gamma interleukin 10 laboratory mouse macrophage macrophage inflammatory proteins monocyte chemoattractant protein 1 physiologic stressor postoperative state protein biosynthesis secondary infection surgery tumor necrosis factor alpha
中文摘要
描述(来自申请人摘要的逐字记录):麻醉/手术
使患者易患医院获得性肺炎的机制,
没有完全定义。病毒性呼吸道感染的存在
(RTI)在麻醉/手术期间,
反应我们实验室的证据表明麻醉/手术
诱导细胞因子应答的变化(例如,TNF α、MIP-2、IFN γ),
白细胞募集和流感RTI的肺损伤。这些响应是
也是宿主对细菌病原体的先天防御的关键。我们的重点是
研究病毒RTI期间使宿主易患
术后细菌性肺炎我们假设麻醉/手术将
在一个过程中的不同时期,
通过改变前和后细胞因子的表达,
从而降低抗菌防御。目标#1将评估
流感期间麻醉/手术对细菌清除、炎症细胞
内流和细胞因子表达。我们预测
流感期间的剖腹手术将促进MCP-1的相对表达,
IL-10超过TNF α、MIP-2和IFN γ。目标#2:将离体评估
剖腹手术和流感对a)LPS刺激的aMphi细胞因子的联合作用
表达和吞噬活性,和B)体外抗MCP-1的能力,
抗IL-10或IFN γ给药以改善M功能障碍。我们推测
流感期间的剖腹手术会改变aMphi的调节功能,
由于选择性增强表达而降低效应子功能
与促炎细胞因子相比,最后,在目标#3中,我们将检查
内源性细胞因子在抑制抗菌药物中的作用
选择性细胞因子介导的流感期间剖腹手术后的防御
操纵细菌清除、炎性细胞流入和细胞因子
水平将被评估。我们预期IL-10或MCP-1的中和,
给予IFN γ或增加TNF α表达将改善
剖腹手术后的抗菌宿主防御,
流感。这些研究将检查导致改变的机制,
病毒性RTI后手术后的细菌清除,评估
手术后肺炎的发病机制,并建议免疫佐剂
预防这种并发症的策略。
英文摘要
DESCRIPTION (Verbatim from the Applicant's Abstract): Anesthesia/surgery
predisposes the patient to develop nosocomial pneumonia by mechanisms that are
not completely defined. The presence of a viral respiratory tract infection
(RTI) during anesthesia/surgery further complicates the host antibacterial
response. Evidence from our laboratory has demonstrated anesthesia/surgery
induces changes in cytokine response (e.g., TNFalpha, MIP-2, IFNgamma),
leukocyte recruitment, and lung injury to influenza RTI. These responses are
also critical to innate host defenses against bacterial pathogens. Our focus is
to examine cellular mechanisms during a viral RTI that predispose the host to a
post-surgical bacterial pneumonia. We hypothesize that anesthesia/surgery will
change host responses differently during distinct periods in the course of a
viral RTI by altering expression of pro- and antiinflammatory cytokines,
thereby decreasing antibacterial defenses. Aim #1 will assess the effects of
anesthesia/surgery during influenza on bacterial clearance, inflammatory cell
influx, and cytokine expression an Escherichia coli challenge. We predict that
laparotomy during influenza will promote the relative expression of MCP-1 and
IL-10 over TNFalpha, MIP-2, and IFNgamma. Aim #2: will assess ex vivo the
combined effect of laparotomy and influenza on a) LPS stimulated aMphi cytokine
expression and phagocytic activity, and b) the ability of in vitro antiMCP-1,
antiIL-10, or IFNgamma administration to improve M dysfunction. We postulate
that laparotomy during influenza will alter aMphi regulatory functions and
decrease effector functions as a result of selective enhancement of expression
anti-compared to proinflammatory cytokines. Finally, in Aim #3, we will examine
the contribution of endogenous cytokines in the suppression of antibacterial
defenses following laparotomy during influenza by selective cytokine
manipulations. Bacterial clearance, inflammatory cell influx, and cytokine
levels will be assessed. We anticipate that neutralization of IL-10 or MCP-1,
administration of IFNgamma, or increased TNFalphaexpression will improve
antibacterial host defenses following laparotomy during physical signs of
influenza. These studies will examine mechanisms that lead to alterations in
bacterial clearance post-surgically following a viral RTI, assess the
pathogenesis of post-surgical pneumonia in general, and suggest immune adjuvant
strategies to prevent this complication.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immunotherapy for acute lung injury secondary to influenza
-
批准号:10373987
-
项目类别:
-
资助金额:$43.68万
-
财政年份:2020
-
负责人:PAUL R KNIGHT III
-
依托单位:
Immunotherapy for acute lung injury secondary to influenza
-
批准号:10599904
-
项目类别:
-
资助金额:$43.68万
-
财政年份:2020
-
负责人:PAUL R KNIGHT III
-
依托单位:
Immunotherapy for acute lung injury secondary to influenza
-
批准号:10133140
-
项目类别:
-
资助金额:$43.68万
-
财政年份:2020
-
负责人:PAUL R KNIGHT III
-
依托单位:
Anesthesiology Research Training Program
-
批准号:8706185
-
项目类别:
-
资助金额:$19.72万
-
财政年份:2012
-
负责人:PAUL R KNIGHT III
-
依托单位:
Anesthesiology Research Training Program
-
批准号:10158525
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:PAUL R KNIGHT III
-
依托单位:
Anesthesiology Research Training Program
-
批准号:8494061
-
项目类别:
-
资助金额:$19.46万
-
财政年份:2012
-
负责人:PAUL R KNIGHT III
-
依托单位:
Anesthesiology Research Training Program
-
批准号:8898098
-
项目类别:
-
资助金额:$19.44万
-
财政年份:2012
-
负责人:PAUL R KNIGHT III
-
依托单位:
Anesthesiology Research Training Program
-
批准号:9068157
-
项目类别:
-
资助金额:$20.29万
-
财政年份:2012
-
负责人:PAUL R KNIGHT III
-
依托单位:
Anesthesiology Research Training Program
-
批准号:8214326
-
项目类别:
-
资助金额:$12.67万
-
财政年份:2012
-
负责人:PAUL R KNIGHT III
-
依托单位:
Anesthesiology Research Training Program
-
批准号:9209767
-
项目类别:
-
资助金额:$21.23万
-
财政年份:2012
-
负责人:PAUL R KNIGHT III
-
依托单位:
Influenza therapy by Au-nanorod 5'PPP-NS1-siRNA/cDNA targeting of bronchial cells
-
批准号:7897618
-
项目类别:
-
资助金额:$39.61万
-
财政年份:2009
-
负责人:PAUL R KNIGHT III
-
依托单位:
Influenza therapy by Au-nanorod 5'PPP-NS1-siRNA/cDNA targeting of bronchial cells
-
批准号:7688443
-
项目类别:
-
资助金额:$38.54万
-
财政年份:2009
-
负责人:PAUL R KNIGHT III
-
依托单位:
Host response to post-operative pneumonia
-
批准号:6896250
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2001
-
负责人:PAUL R KNIGHT III
-
依托单位:
Host response to post-operative pneumonia
-
批准号:6605296
-
项目类别:
-
资助金额:$8.13万
-
财政年份:2001
-
负责人:PAUL R KNIGHT III
-
依托单位:
Host response to post-operative pneumonia
-
批准号:6750028
-
项目类别:
-
资助金额:$48.63万
-
财政年份:2001
-
负责人:PAUL R KNIGHT III
-
依托单位:
Host response to post-operative pneumonia
-
批准号:6632186
-
项目类别:
-
资助金额:$48.36万
-
财政年份:2001
-
负责人:PAUL R KNIGHT III
-
依托单位:
Host response to post-operative pneumonia
-
批准号:6401732
-
项目类别:
-
资助金额:$36.51万
-
财政年份:2001
-
负责人:PAUL R KNIGHT III
-
依托单位:
Pathogenesis of Aspiration Pneumonitis
-
批准号:7577426
-
项目类别:
-
资助金额:$39.63万
-
财政年份:1996
-
负责人:PAUL R KNIGHT III
-
依托单位:
Pathogenesis of Aspiration Pneumonitis
-
批准号:7388230
-
项目类别:
-
资助金额:$39.63万
-
财政年份:1996
-
负责人:PAUL R KNIGHT III
-
依托单位:
Pathogenesis of Aspiration Pneumonitis
-
批准号:7780039
-
项目类别:
-
资助金额:$39.63万
-
财政年份:1996
-
负责人:PAUL R KNIGHT III
-
依托单位: